HST Global, Inc., an integrated biotechnology health and wellness company, announced today that it has commenced a project with EBITDA Capital, LLC for both shareholder participation and health and wellness center operations within Saudi Arabia.

EBITDA Capital, LLC will begin working with their contacts and clients within the Kingdom of Saudi Arabia. Key clientele within the Royal Family have shown interest in becoming shareholders in HSTC. They are also interested in operating a health and wellness clinic based within the Gulf Cooperation Council Countries (GCC). If one (or several) were to be built, they would include both for-profit and non-profit treatment facilities in support of HSTC’s late stage cancer applications. The company would be responsible for the training, maintenance and management development in these clinics.

Mr. Chet Noblett, Managing General Partner of EBITDA, is facilitating the initial negotiations and is leveraging his long

Earlier this year, HST Global announced that it contracted EBITDA Capital LLC of Newport Beach California and its group of associates to join HST-Global’s efforts in working toward an overall corporate strategy. The company also announced Former United States Congressman Bill Sarpalius, the President and CEO of Advantage Associates International, has been given the role of interfacing with the political community in Washington DC.

Mr. Sarpalius said, “We are excited to be in a position to raise the awareness of both the public and members of the government about HST’s treatment solution. The opportunity of bringing a treatment for late stage cancer is something which we all want to see expanded and made use of in the treatment community.”

Mr. Ron Howell, CEO and President of HST Global commented, “Through the use of the EBITDA Capital resources we at HST Global can focus on the issue of bringing awareness of our treatment